Simple Pharma prescribed boost for expansion plans
Simple Pharma
Simple Pharma's purpose is to be the best home for pharmaceutical products and improve access to medicines worldwide. Simple Pharma partners with pharma companies to offer digitally enabled end-to-end operations, distribution, and compliance services.
Santander's funding will help to boost Simple Pharma's growth plans, including driving the expansion of Simple Pharma's service offering and the global growth of its men's health product portfolio commercialised by sister company Androlabs. The portfolio consists of two products, Testavan and Vitaros.
Santander’s expertise ensures we have the flexibility to accelerate our growth expanding into new markets, adding more products to our portfolio, and improving our capabilities. We’re working on new projects which will improve patient access to medicines - we’re excited to see where our partnership can take us!
COO and Co-Founder, Simple Pharma
Santander is now looking forward to supporting Simple Pharma’s wider international growth plans. The platform company currently operates in more than 20 countries and is aiming to expand its geographical scope to become a globally important pharmaceutical company.
We’re delighted to have partnered with Simple Pharma, backing a strong management team with impressive international growth to date and ambitious future plans. We look forward to growing the relationship in the coming years.
Director, Growth Capital, Structured Finance, Santander
Related content
